Tag: Traditional Chinese Medicine

  • Herbalgy Launches 27-Year Campaign in Hong Kong with Keung To

    Herbalgy Launches 27-Year Campaign in Hong Kong with Keung To

    Hong Kong topical pain relief maker Herbalgy Pharmaceutical launched an anniversary retail push on September 16. The promotion features 27 per cent discounts and tiered basket incentives on its direct-to-consumer online store.

    The campaign pairs the brand’s 27th year in business with Hong Kong pop idol Keung To. The singer turns 27 this year.

    Discounts and High-Ticket Spend Tiers

    Shoppers face three volume incentives on the brand’s website. A one-day flash sale cut prices by 27 per cent across the catalogue on September 16. A month-long gift promotion runs through October 15. That offer gives customers an exclusive Keung To merchandise gift on net purchases of HK$430 or more.

    To lift order values among regular buyers, the company added an upper tier requiring a single net spend of HK$2,700. Reaching that threshold yields 27 units of 5 ml portable pain relief products.

    The Direct-to-Consumer Push for Traditional Formulations

    Traditional Chinese medicine makers across Hong Kong face steady pressure to turn pharmacy foot traffic into direct digital accounts. Medicated oils and plasters rely heavily on neighborhood dispensaries. In those physical shops, distributor fees and shelf rental costs squeeze profit margins.

    By partnering with a celebrity ambassador, Herbalgy aims to bypass retail intermediaries and secure higher gross margins. Retaining those buyers after discounts expire remains the central commercial risk. That challenge grows when asking shoppers to spend HK$2,700 on everyday topical remedies.

    Roots in Hong Kong Manufacturing

    Chinese medicine practitioner Professor Wong Tin Chee founded Herbalgy in 1999. He built the business on formulas created by his father, medicated oil producer Wong To Yick. Wong set up a Good Manufacturing Practice facility in Hong Kong to make registered proprietary Chinese medicines, later adding brands such as Touch Cool and Tibet Red.

    Digital sales and the Keung To gift promotion continue on Herbalgy’s official storefront through October 15, 2026.

  • China Finds High Nitrite Levels in Malaysian Edible Birds Nests

    China Finds High Nitrite Levels in Malaysian Edible Birds Nests

    Chinese regulators discovered nitrite levels averaging 4,400 milligrams per kilogram in edible bird’s nests imported from Malaysia, sixty times higher than the national safety limit.

    The Zhejiang Provincial Administration for Industry and Commerce tested blood-red cubilose across 491 dealers before issuing the health alert. Under national rules, nitrite content cannot exceed 70 milligrams per kilogram. Investigators found that dealers applied chemical dyes to standard nests to sell them as rare blood-red varieties, generating elevated concentrations of nitrite, a compound linked to cancer risks.

    Tainted stock pulled from shelves

    Beijing Tongrentang Co. Pulled all edible bird’s nests from its retail counters in mainland China and overseas locations. The traditional Chinese medicine merchant enacted the withdrawal two days after Zhejiang officials issued their findings.

    Bird’s nests rank among the most expensive luxury food items in Asia, commanding prices up to 10,000 US dollars per kilogram in markets across China, Hong Kong and the United States. Premium wellness retailers face immediate margin disruption when quality failures occur in products sold specifically for health maintenance.

    Export supply lines under pressure

    Malaysia operates as the world’s largest supplier of edible bird’s nests and ships 95 per cent of its output directly to China. The test results in Zhejiang expose supply chain weaknesses in cross-border trade for unrefined animal secretions, putting pressure on upstream processors to prove product purity before goods clear Chinese customs.

    China’s State Food and Drug Administration has not issued a nationwide directive on imported cubilose, leaving retail buyers waiting for central border inspectors to set updated testing protocols.

  • Chinese medicine group expanding

    Chinese medicine group expanding

    Traditional Chinese medicine brand Tong Ren Tang has accelerated its overseas expansion, opening nine stores abroad last year.

    It has developed 31 branches in 25 countries and regions, has 115 retail sites, clinics and health centers, and served more than 30 million patients.

    Beijing Tong Ren Tang Group chairman Mei Qun says there have been three steps in its international development: in 1993, it started its overseas development in Hong Kong; in 2003, it established Beijing Tong Ren Tang International in Hong Kong; and in 2013, Beijing Tong Ren Tang Chinese Medicine was listed in Hong Kong and started developing in major European markets.

    Group deputy-GM Ding Yongling says the group opened nine new stores last year in six countries and regions, including Hong Kong. Apart from Chinese medicine stores, the group also developed Chinese medicine clinics and health centres overseas.

  • Traditional Chinese Medicine Retailer Accelerates Overseas Expansion

    Traditional Chinese Medicine Retailer Accelerates Overseas Expansion

    The time-honored traditional Chinese medicine brand Tong Ren Tang says it accelerated its overseas expansion and opened nine new stores in the overseas market in 2015.

    In reporting the company’s results for last year, the company says it has developed 31 branches in 25 countries and regions outside China, operating 115 retail sites, traditional Chinese medicine clinics, and traditional Chinese medicine health centers. It served over 30 million patients in those countries and regions.

    Mei Qun, chairman of Beijing Tong Ren Tang Group, said that based on the planning of Tong Ren Tang, its international development is divided into three steps. In 1993, the group started its overseas development in Hong Kong; in 2003, they established Beijing Tong Ren Tang International Co., Ltd. in Hong Kong; and in 2013, Beijing Tong Ren Tang Chinese Medicine Co., Ltd. was successfully listed in Hong Kong and started developing in major European markets.

    Ding Yongling, deputy general manager of Beijing Tong Ren Tang Group, said that in 2015, the group opened nine new stores in six countries and regions, including Hong Kong, Germany, United Arab Emirates, New Zealand, Sweden, and the Czech Republic. Apart from Chinese medicine stores, the group also developed Chinese medicine clinics and health centers in foreign countries.